Study of the use of a spironolactone and angiotensin‐converting enzyme inhibitor combination: a population‐based analysis

J. Besançon,L. Lagarce,B. Diquet,P. Lainé‐Cessac
DOI: https://doi.org/10.1002/pds.1511
2008-02-01
Pharmacoepidemiology and Drug Safety
Abstract:To analyse the conditions of use of the drug combination in outpatients.
What problem does this paper attempt to address?